Crossref journal-article
Portland Press Ltd.
Biochemical Society Transactions (288)
Abstract

The essential metals iron, zinc and copper deposit near the Aβ (amyloid β-peptide) plaques in the brain cortex of AD (Alzheimer's disease) patients. Plaque-associated iron and zinc are in neurotoxic excess at 1 mM concentrations. APP (amyloid precursor protein) is a single transmembrane metalloprotein cleaved to generate the 40–42-amino-acid Aβs, which exhibit metal-catalysed neurotoxicity. In health, ubiquitous APP is cleaved in a non-amyloidogenic pathway within its Aβ domain to release the neuroprotective APP ectodomain, APP(s). To adapt and counteract metal-catalysed oxidative stress, as during reperfusion from stroke, iron and cytokines induce the translation of both APP and ferritin (an iron storage protein) by similar mechanisms. We reported that APP was regulated at the translational level by active IL (interleukin)-1 (IL-1-responsive acute box) and IRE (iron-responsive element) RNA stem–loops in the 5′ untranslated region of APP mRNA. The APP IRE is homologous with the canonical IRE RNA stem–loop that binds the iron regulatory proteins (IRP1 and IRP2) to control intracellular iron homoeostasis by modulating ferritin mRNA translation and transferrin receptor mRNA stability. The APP IRE interacts with IRP1 (cytoplasmic cis-aconitase), whereas the canonical H-ferritin IRE RNA stem–loop binds to IRP2 in neural cell lines, and in human brain cortex tissue and in human blood lysates. The same constellation of RNA-binding proteins [IRP1/IRP2/poly(C) binding protein] control ferritin and APP translation with implications for the biology of metals in AD.

Bibliography

Rogers, J. T., Bush, A. I., Cho, H.-H., Smith, D. H., Thomson, A. M., Friedlich, A. L., Lahiri, D. K., Leedman, P. J., Huang, X., & Cahill, C. M. (2008). Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer’s disease. Biochemical Society Transactions, 36(6), 1282–1287.

Authors 10
  1. Jack T. Rogers (first)
  2. Ashley I. Bush (additional)
  3. Hyan-Hee Cho (additional)
  4. Deborah H. Smith (additional)
  5. Andrew M. Thomson (additional)
  6. Avi L. Friedlich (additional)
  7. Debomoy K. Lahiri (additional)
  8. Peter J. Leedman (additional)
  9. Xudong Huang (additional)
  10. Catherine M. Cahill (additional)
References 46 Referenced 122
  1. 10.1038/nrn1537 / Nat. Rev. Neurosci. / Iron, brain ageing and neurodegenerative disorders by Zecca (2004)
  2. 10.1212/01.wnl.0000262033.01945.9a / Neurology / Individual dopaminergic neurons show raised iron levels in Parkinson disease by Oakley (2007)
  3. 10.1016/j.neulet.2005.07.032 / Neurosci. Lett. / Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status by Fernaeus (2005)
  4. 10.1002/ana.1252 / Ann. Neurol. / Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord by Olsen (2001)
  5. 10.1073/pnas.88.23.10540 / Proc. Natl. Acad. Sci. U.S.A. / Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease by Smith (1991)
  6. 10.1021/bk-2005-0903.ch013 / Medicinal Inorganic Chemistry (ACS Symposium Series 903) / Amyloid precursor protein and ferritin translation: implications for metals and Alzheimer's disease therapeutics by Rogers (2005)
  7. 10.1073/pnas.0404349101 / Proc. Natl. Acad. Sci. U.S.A. / A role for heme in Alzheimer's disease: heme binds amyloid β and has altered metabolism by Atamna (2004)
  8. 10.2174/1389450043345272 / Curr. Drug Targets / Metal and inflammatory targets for Alzheimer's disease by Rogers (2004)
  9. 10.1006/bbrc.1995.2678 / Biochem. Biophys. Res. Commun. / The role of iron in β amyloid toxicity by Schubert (1995)
  10. 10.1074/jbc.274.52.37111 / J. Biol. Chem. / Cu(II) potentiation of Alzheimer Aβ neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction by Huang (1999)
  11. 10.1523/JNEUROSCI.21-05-01444.2001 / J. Neurosci. / α-1-Antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease by Nilsson (2001)
  12. 10.1016/j.jsb.2005.12.011 / J. Struct. Biol. / Metal exposure and Alzheimer's pathogenesis by Liu (2006)
  13. 10.1016/0006-3223(94)90047-7 / Biol. Psychiatry / In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI by Bartzokis (1994)
  14. 10.1016/S0022-510X(98)00092-6 / J. Neurol. Sci. / Copper, iron and zinc in Alzheimer's disease senile plaques by Lovell (1998)
  15. 10.1016/S0006-8993(02)03893-3 / Brain Res. / A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease by Shin (2003)
  16. 10.1016/0140-6736(91)92978-B / Lancet / Intramuscular desferrioxamine in patients with Alzheimer's disease by Crapper McLachlan (1991)
  17. 10.1074/jbc.M207435200 / J. Biol. Chem. / An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript by Rogers (2002)
  18. 10.1136/jmg.2003.015552 / J. Med. Genet. / Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease by Robson (2004)
  19. 10.1096/fj.06-6397com / FASEB J. / Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE by Lee (2007)
  20. 10.1002/jnr.10463 / J. Neurosci. Res. / Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress by Thompson (2003)
  21. 10.1016/S0006-8993(00)03196-6 / Brain Res. / Metallothionein III is reduced in Alzheimer's disease by Yu (2001)
  22. 10.1086/321261 / Am. J. Hum. Genet. / A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload by Kato (2001)
  23. 10.1038/84859 / Nat. Genet. / Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice by LaVaute (2001)
  24. 10.1126/science.271.5254.1406 / Science / The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I) by Multhaup (1996)
  25. 10.1038/416535a / Nature / Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo by Walsh (2002)
  26. 10.1126/science.2110384 / Science / Protease nexin-II (amyloid β-protein precursor): a platelet α-granule protein by Van Nostrand (1990)
  27. 10.1016/S0021-9258(19)37165-0 / J. Biol. Chem. / Ferritin: a cytoprotective antioxidant strategem of endothelium by Balla (1992)
  28. 10.1016/S0169-328X(97)00133-2 / Mol. Brain Res. / Reversible ischemia increases levels of Alzheimer amyloid protein precursor without increasing levels of mRNA in the rabbit spinal cord by Komori (1997)
  29. 10.1002/ana.10751 / Ann. Neurol. / Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration by Fujioka (2003)
  30. 10.1073/pnas.91.16.7450 / Proc. Natl. Acad. Sci. U.S.A. / Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor by Roch (1994)
  31. 10.1002/jnr.20864 / J. Neurosci. Res. / Interleukin-1α stimulates non-amyloidogenic pathway by α-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase by Bandyopadhyay (2006)
  32. 10.1016/S0021-9258(19)51039-0 / J. Biol. Chem. / Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region by Zaidi (1994)
  33. 10.1371/journal.pbio.0050052 / PLoS Biol. / FMRP mediates mGluR5-dependent translation of amyloid precursor protein by Westmark (2007)
  34. 10.1007/978-3-211-33328-0_25 / J. Neural Transm. Suppl. / Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5′ untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator by Bandyopadhyay (2006)
  35. 10.1001/archneur.59.11.1793 / Arch. Neurol. / Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease by Athan (2002)
  36. 10.1016/S1357-2725(99)00080-1 / Int. J. Biochem. Cell Biol. / Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation by Thomson (1999)
  37. 10.1261/rna.464807 / RNA / Evolution of the iron-responsive element by Piccinelli (2007)
  38. 10.1196/annals.1332.003 / Ann. N.Y. Acad. Sci. / The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5′-untranslated region by Venti (2004)
  39. 10.1073/pnas.86.19.7611 / Proc. Natl. Acad. Sci. U.S.A. / Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease by Griffin (1989)
  40. 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N / Ann. Neurol. / Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism by Grimaldi (2000)
  41. 10.1074/jbc.M502951200 / J. Biol. Chem. / The acute box cis-element in human heavy ferritin mRNA 5′-untranslated region is a unique translation enhancer that binds poly(C)-binding proteins by Thomson (2005)
  42. 10.1074/jbc.274.10.6421 / J. Biol. Chem. / Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences by Rogers (1999)
  43. 10.1016/S0092-8674(01)00212-4 / Cell / Lipoxygenase mRNA silencing in erythroid differentiation: the 3′UTR regulatory complex controls 60S ribosome subunit joining by Ostareck (2001)
  44. 10.1128/MCB.19.7.4572 / Mol. Cell. Biol. / Assembly of the α-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3′ untranslated region determinant and poly(C) binding protein αCP by Chkheidze (1999)
  45. 10.1016/S0306-4522(01)00522-X / Neuroscience / Expression of poly(C)-binding proteins is differentially regulated by hypoxia and ischemia in cortical neurons by Zhu (2002)
  46. 10.1016/S0896-6273(01)00317-8 / Neuron / Treatment with a copper–zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice by Cherny (2001)
Dates
Type When
Created 16 years, 8 months ago (Dec. 2, 2008, 12:27 p.m.)
Deposited 3 years, 9 months ago (Nov. 17, 2021, 8 p.m.)
Indexed 3 weeks, 6 days ago (Aug. 6, 2025, 8:14 a.m.)
Issued 16 years, 9 months ago (Nov. 19, 2008)
Published 16 years, 9 months ago (Nov. 19, 2008)
Published Online 16 years, 9 months ago (Nov. 19, 2008)
Published Print 16 years, 9 months ago (Dec. 1, 2008)
Funders 0

None

@article{Rogers_2008, title={Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer’s disease}, volume={36}, ISSN={1470-8752}, url={http://dx.doi.org/10.1042/bst0361282}, DOI={10.1042/bst0361282}, number={6}, journal={Biochemical Society Transactions}, publisher={Portland Press Ltd.}, author={Rogers, Jack T. and Bush, Ashley I. and Cho, Hyan-Hee and Smith, Deborah H. and Thomson, Andrew M. and Friedlich, Avi L. and Lahiri, Debomoy K. and Leedman, Peter J. and Huang, Xudong and Cahill, Catherine M.}, year={2008}, month=nov, pages={1282–1287} }